WO2006124698A3 - Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee - Google Patents

Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee Download PDF

Info

Publication number
WO2006124698A3
WO2006124698A3 PCT/US2006/018589 US2006018589W WO2006124698A3 WO 2006124698 A3 WO2006124698 A3 WO 2006124698A3 US 2006018589 W US2006018589 W US 2006018589W WO 2006124698 A3 WO2006124698 A3 WO 2006124698A3
Authority
WO
WIPO (PCT)
Prior art keywords
vomiting
induced nausea
chemotherapy
delayed chemotherapy
delayed
Prior art date
Application number
PCT/US2006/018589
Other languages
English (en)
Other versions
WO2006124698A2 (fr
Inventor
Kevin Rose
Original Assignee
Unimed Pharmaceuticals Inc
Kevin Rose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals Inc, Kevin Rose filed Critical Unimed Pharmaceuticals Inc
Priority to AU2006247526A priority Critical patent/AU2006247526A1/en
Priority to MX2007014188A priority patent/MX2007014188A/es
Priority to CA002608399A priority patent/CA2608399A1/fr
Priority to BRPI0610364-2A priority patent/BRPI0610364A2/pt
Priority to EP06770314A priority patent/EP1881757A4/fr
Priority to JP2008511438A priority patent/JP2008540570A/ja
Publication of WO2006124698A2 publication Critical patent/WO2006124698A2/fr
Publication of WO2006124698A3 publication Critical patent/WO2006124698A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)

Abstract

Dans plusieurs modes de réalisation, l'invention concerne des compositions pharmaceutiques contenant delta-9-tetrahydrocannabinol, ainsi que des procédés d'administration de ces compositions avant la chimiothérapie afin de prévenir ou de réduire le développement de nausées et de vomissements induits par chimiothérapie différée.
PCT/US2006/018589 2005-05-13 2006-05-15 Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee WO2006124698A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2006247526A AU2006247526A1 (en) 2005-05-13 2006-05-15 Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting
MX2007014188A MX2007014188A (es) 2005-05-13 2006-05-15 Tratamiento con dronabinol de nauseas y vomitos tardios inducidos por quimioterapia.
CA002608399A CA2608399A1 (fr) 2005-05-13 2006-05-15 Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee
BRPI0610364-2A BRPI0610364A2 (pt) 2005-05-13 2006-05-15 tratamento, com dronabinol, de náusea e vÈmito retardados induzidos por quimioterapia
EP06770314A EP1881757A4 (fr) 2005-05-13 2006-05-15 Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee
JP2008511438A JP2008540570A (ja) 2005-05-13 2006-05-15 遅発性化学療法誘発悪心及び嘔吐のドロナビノール治療

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US68051905P 2005-05-13 2005-05-13
US60/680,519 2005-05-13
US69467505P 2005-06-29 2005-06-29
US60/694,675 2005-06-29
US70342005P 2005-07-29 2005-07-29
US60/703,420 2005-07-29

Publications (2)

Publication Number Publication Date
WO2006124698A2 WO2006124698A2 (fr) 2006-11-23
WO2006124698A3 true WO2006124698A3 (fr) 2007-06-21

Family

ID=37431948

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/018589 WO2006124698A2 (fr) 2005-05-13 2006-05-15 Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee

Country Status (9)

Country Link
US (1) US20070072938A1 (fr)
EP (1) EP1881757A4 (fr)
JP (1) JP2008540570A (fr)
KR (1) KR20080021024A (fr)
AU (1) AU2006247526A1 (fr)
BR (1) BRPI0610364A2 (fr)
CA (1) CA2608399A1 (fr)
MX (1) MX2007014188A (fr)
WO (1) WO2006124698A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200701246A1 (ru) * 2004-12-09 2008-06-30 Инсис Терапьютикс, Инк. Стабильные при комнатной температуре составы дронабинола
EP2046290A4 (fr) * 2006-08-04 2011-08-17 Insys Therapeutics Inc Formulations aqueuses de dronabinol
WO2008144475A1 (fr) 2007-05-17 2008-11-27 California Pacific Medical Center Procédés et compositions pour traiter le cancer
US20090181080A1 (en) * 2007-08-06 2009-07-16 Insys Therapeutics Inc. Oral cannabinnoid liquid formulations and methods of treatment
GB2460672B (en) * 2008-06-04 2012-01-04 Gw Pharma Ltd Cannabinoids in combination with non-cannabinoid chemotherapeutic agents that are alkylating agents
GB2471987B (en) * 2008-06-04 2012-02-22 Gw Pharma Ltd Anti-tumoural effects of cannabinoid combinations
US10350233B2 (en) * 2009-04-06 2019-07-16 Joshua D. Levine Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
CA2822738C (fr) 2010-12-22 2021-06-08 Exonoid Medical Devices Ltd. Procede et systeme d'administration de medicament
GB2516814B (en) 2013-06-19 2016-08-31 Otsuka Pharma Co Ltd Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
WO2015200049A1 (fr) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Produits associés à un aérosol doseur, et procédés d'utilisation
WO2016001922A1 (fr) 2014-06-30 2016-01-07 Syqe Medical Ltd. Procédés, dispositifs et systèmes utilisables en vue de l'administration pulmonaire d'agents actifs
EP3160552B1 (fr) 2014-06-30 2019-05-08 Syqe Medical Ltd. Cartouche de dose de médicament pour un dispositif d'inhalateur
BR112016030955B1 (pt) 2014-06-30 2022-03-22 Syqe Medical Ltd. Dispositivo inalador
EP3160553B1 (fr) 2014-06-30 2021-10-20 Syqe Medical Ltd. Dispositif utilisables en vue de la vaporisation et de l'inhalation de substances isolées
US11298477B2 (en) 2014-06-30 2022-04-12 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
EP3160565B1 (fr) 2014-06-30 2021-08-18 Syqe Medical Ltd. Dispositifs et systèmes pour administration pulmonaire d'agents actifs
US11806331B2 (en) 2016-01-06 2023-11-07 Syqe Medical Ltd. Low dose therapeutic treatment
US20200113847A1 (en) * 2018-10-10 2020-04-16 Tilray, Inc. Methods and formulations for treating chemotherapy-induced nausea and vomiting
CN114650809A (zh) * 2019-10-03 2022-06-21 斯塔顿治疗公司 屈大麻酚的透皮递送

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635274B1 (en) * 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
US6503532B1 (en) * 2001-04-13 2003-01-07 Murty Pharmaceuticals, Inc. Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635274B1 (en) * 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"FACTBITES: Topic: Dronabinol", pages 1 - 2, XP008096494, Retrieved from the Internet <URL:http://www.factbites.com/topics/dronabinol> [retrieved on 20080915] *
"Marinol(R) Helps to Reduce Delayed Chemotherapy-Induced Nausea and Vomiting (CINV)", CANCER/ONCOLOGY NEWS, 16 May 2005 (2005-05-16), pages 1 - 3, XP003014403 *
HOLLISTER L.E.: "Health Aspects of Cannabis", PHARMACOLOGICAL REVIEWS, 1986, pages 1 - 20, XP002902072 *
ZEESE K B: "Research Findings on Medicinal Properties of Marijuana.", pages 1 - 14, XP008096481, Retrieved from the Internet <URL:http://www.ndsn.org/jan97/zeesemm.html> [retrieved on 20080915] *

Also Published As

Publication number Publication date
US20070072938A1 (en) 2007-03-29
JP2008540570A (ja) 2008-11-20
KR20080021024A (ko) 2008-03-06
EP1881757A4 (fr) 2008-09-10
BRPI0610364A2 (pt) 2010-06-15
WO2006124698A2 (fr) 2006-11-23
MX2007014188A (es) 2008-02-05
EP1881757A2 (fr) 2008-01-30
CA2608399A1 (fr) 2006-11-23
AU2006247526A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
WO2006124698A3 (fr) Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2009027644A3 (fr) Composition
WO2006096434A3 (fr) Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l&#39;anxiete
WO2008039218A3 (fr) Inhibiteurs de la tyrosine kinase de bruton
WO2007093624A3 (fr) Nouvelles compositions pharmaceutiques pour le traitement du trouble d&#39;hyperactivité avec déficit de l&#39;attention
EP2450360A3 (fr) (S)-N-Méthylnaltrexone
WO2007026024A3 (fr) Benzodiazepines en tant qu&#39;inhibiteurs du vhc
WO2006086562A3 (fr) Derives de phenylazetidinone
WO2008073448A3 (fr) Formulations pharmaceutiques et leurs procédés de production
WO2009109927A3 (fr) Agonistes du récepteur glp-1 et ingrédients pharmaceutiques actifs apparentés pour le traitement du cancer
WO2006012527A8 (fr) Groupes de liaison bivalents et conjugués de ceux-ci
WO2005107747A3 (fr) Preparations de diindolymethane destinee de traitement de leiomyomes
WO2007087068A3 (fr) Inhibiteurs de tyrosine kinase et leurs utilisations
WO2005112633A3 (fr) Composes et compositions pour administration d’agents actifs
WO2009121039A3 (fr) Administration de compositions de benzodiazépine
HRP20050676B1 (hr) Tekuä†i farmaceutski oblici palonosetrona
WO2007056142A3 (fr) Procedes de prevention du syndrome serotoninergique et compositions utilisees a cette fin
WO2006130703A3 (fr) Formulations a liberation modifiee de medicaments anti-irritabilite
WO2006118884A3 (fr) Dispositifs d&#39;administration de medicaments, composants, systemes et methodes associes
WO2005009460A3 (fr) Composition pharmaceutique comportant l&#39;activine a, l&#39;alk-4 ou leurs derives pour le traitement des troubles ophtalmiques ou du cancer
WO2009038095A1 (fr) Composition comprenant de la sésamine et de la vitamine b1
WO2006042478A8 (fr) Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation
EP1503748A4 (fr) Medicaments servant a attenuer la neurotoxicite induite par le taxane
WO2006130702A3 (fr) Formulations a liberation modifiee de medicaments antihypertenseurs

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680016449.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006770314

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 8661/DELNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2006247526

Country of ref document: AU

Ref document number: MX/a/2007/014188

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2608399

Country of ref document: CA

Ref document number: 2008511438

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007141134

Country of ref document: RU

Ref document number: 1020077029175

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0610364

Country of ref document: BR

Kind code of ref document: A2